IL323948A - תולדות אימידזוטריאזין כמאפנני il-17 - Google Patents

תולדות אימידזוטריאזין כמאפנני il-17

Info

Publication number
IL323948A
IL323948A IL323948A IL32394825A IL323948A IL 323948 A IL323948 A IL 323948A IL 323948 A IL323948 A IL 323948A IL 32394825 A IL32394825 A IL 32394825A IL 323948 A IL323948 A IL 323948A
Authority
IL
Israel
Prior art keywords
formula
compound
pharmaceutically acceptable
acceptable salt
treatment
Prior art date
Application number
IL323948A
Other languages
English (en)
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of IL323948A publication Critical patent/IL323948A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
IL323948A 2023-04-17 2025-10-15 תולדות אימידזוטריאזין כמאפנני il-17 IL323948A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2305585.8A GB202305585D0 (en) 2023-04-17 2023-04-17 Therapeutic agents
PCT/EP2024/060131 WO2024218030A1 (en) 2023-04-17 2024-04-15 Imidazotriazine derivatives as il-17 modulators

Publications (1)

Publication Number Publication Date
IL323948A true IL323948A (he) 2025-12-01

Family

ID=86497343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323948A IL323948A (he) 2023-04-17 2025-10-15 תולדות אימידזוטריאזין כמאפנני il-17

Country Status (12)

Country Link
EP (1) EP4698532A1 (he)
KR (1) KR20250170130A (he)
CN (1) CN121039130A (he)
AR (1) AR132433A1 (he)
AU (1) AU2024257382A1 (he)
CL (1) CL2025003161A1 (he)
CO (1) CO2025014317A2 (he)
GB (1) GB202305585D0 (he)
IL (1) IL323948A (he)
MX (1) MX2025012309A (he)
TW (1) TW202446365A (he)
WO (1) WO2024218030A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089036A2 (en) 2008-01-09 2009-07-16 Schepens Eye Research Institute Therapeutic compositions for treatment of ocular inflammatory disorders
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
AR126255A1 (es) 2021-07-01 2023-10-04 UCB Biopharma SRL Derivados de imidazotriazina como moduladores de il-17

Also Published As

Publication number Publication date
AR132433A1 (es) 2025-06-25
CO2025014317A2 (es) 2025-10-30
CL2025003161A1 (es) 2025-12-12
WO2024218030A1 (en) 2024-10-24
MX2025012309A (es) 2025-11-03
TW202446365A (zh) 2024-12-01
CN121039130A (zh) 2025-11-28
GB202305585D0 (en) 2023-05-31
EP4698532A1 (en) 2026-02-25
AU2024257382A1 (en) 2025-10-09
KR20250170130A (ko) 2025-12-04

Similar Documents

Publication Publication Date Title
JP7163379B2 (ja) Il-17調節剤としてのスピロ環インドリン
AU2017377072B2 (en) Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
AU2016311376B2 (en) Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
WO2020120141A1 (en) Functionalised amine derivatives as il-17 modulators
CN102369200B (zh) 5元杂环化合物的氮杂螺烷基-烷基氨基甲酸酯衍生物、其制备方法和其治疗用途
CA3110767A1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
AU2017201536A1 (en) Pyrimidinyl Tyrosine Kinase Inhibitors
WO2021170631A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2022096412A1 (en) Dicyclopropylmethyl derivatives as il-17 modulators
WO2021170627A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2022096411A1 (en) Dicyclopropylmethyl derivatives as il-17 modulators
WO2024017880A1 (en) Imidazotriazine derivatives as il-17 modulators
EP1943244A1 (en) Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
IL323948A (he) תולדות אימידזוטריאזין כמאפנני il-17
WO2024126249A1 (en) Imidazotriazine derivatives as il-17 modulators
EP4698278A1 (en) Imidazotriazine derivatives as il-17 modulators
KR20190032534A (ko) C5a 수용체 길항제로서의 시클릭 펩티드
WO2024126248A1 (en) Imidazotriazine derivatives as il-17 modulators
WO2024126250A1 (en) Imidazotriazine derivatives as il-17 modulators
JP6757332B2 (ja) RORcモジュレーターとしてのピリダジン誘導体
CA3160508A1 (en) Substituted ((((6-benzylamino-5-fluoropyrimidin-4-yl)amino)methyl)-piperidin-1-yl)acetamide compounds active towards nuclear receptors